6118.HK Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 10:08):

Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally...

Stats
Dagens volum	526 000
Gjennomsnittsvolum	456 616
Markedsverdi	420.32M
EPS	HKD0 ( 2023-08-29 )
Last Dividend	HKD0.0500 ( 2015-05-19 )
Next Dividend	HKD0 ( N/A )
P/E	-13.67
ATR14	HKD0.0130 (1.59%)

Austar Lifesciences Ltd Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Austar Lifesciences Ltd Økonomi

Annual	2023
Omsetning:	HKD1.76B
Bruttogevinst:	HKD336.05M (19.05 %)
EPS:	HKD-0.0636

FY	2023
Omsetning:	HKD1.76B
Bruttogevinst:	HKD336.05M (19.05 %)
EPS:	HKD-0.0636

FY	2022
Omsetning:	HKD2.23B
Bruttogevinst:	HKD462.67M (20.76 %)
EPS:	HKD0.170

FY	2021
Omsetning:	HKD2.02B
Bruttogevinst:	HKD479.01M (23.77 %)
EPS:	HKD0.540

Financial Reports:

No articles found.

Austar Lifesciences Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Austar Lifesciences Ltd Dividend Information - No Dividend Player

Dividend Sustainability Score: 4.80 - low (59.31%) | Divividend Growth Potential Score: 1.476 - No dividend growth expected in the near future

Information

First Dividend	HKD0.0500	2015-05-19
Last Dividend	HKD0.0500	2015-05-19
Next Dividend	HKD0	N/A
Payout Date	2015-06-26
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	HKD0.0500	--
Avg. Dividend % Per Year	0.00%	--
Score	0.95	--
Div. Sustainability Score	4.80
Div.Growth Potential Score	1.476
Div. Directional Score	3.14	--

Next Divdend (Est)
(2024-04-28)

HKD0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.95

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2899.HK	Ex Dividend Knight	2023-05-30	Annually	0.00%
1513.HK	Ex Dividend Knight	2023-07-04	Annually	0.00%
0560.HK	Ex Dividend Junior	2023-06-26	Annually	0.00%
8223.HK	Ex Dividend Junior	2023-06-08	Annually	0.00%
2016.HK	Ex Dividend Junior	2023-05-17	Annually	0.00%
1088.HK	Ex Dividend Knight	2023-06-21	Annually	0.00%
0163.HK	Ex Dividend Junior	2023-09-26	Semi-Annually	0.00%
3709.HK	Ex Dividend Knight	2023-06-14	Annually	0.00%
1665.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
0700.HK	Ex Dividend Knight	2023-05-19	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.000801	1.500	9.98	10.00	[0 - 0.5]
returnOnAssetsTTM	0.000775	1.200	9.97	10.00	[0 - 0.3]
returnOnEquityTTM	0.00205	1.500	-1.088	-1.632	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.336	0.800	8.32	6.65	[1 - 3]
quickRatioTTM	0.992	0.800	8.87	7.10	[0.8 - 2.5]
cashRatioTTM	0.139	1.500	-0.339	-0.508	[0.2 - 2]
debtRatioTTM	0.224	-1.500	6.27	-9.41	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.130	2.00	-0.0433	-0.0866	[0 - 30]
freeCashFlowPerShareTTM	-0.199	2.00	-0.0995	-0.199	[0 - 20]
debtEquityRatioTTM	0.625	-1.500	7.50	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.179	1.000	-0.348	-0.348	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0102	1.000	-2.20	-2.20	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.134	1.000	-1.857	-1.857	[0.2 - 2]
assetTurnoverTTM	0.968	0.800	6.88	5.51	[0.5 - 2]
Total Score				4.80

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	226.26	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.00205	2.50	-0.700	-1.632	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.199	2.00	-0.0663	-0.199	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.130	2.00	-0.0433	-0.0866	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.792	1.500	8.05	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0310	1.000	-3.28	0	[0.1 - 0.5]
Total Score				1.476

Austar Lifesciences Ltd

Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through six segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The company offers liquid and bioprocess systems, including pharmaceutical water, and liquid preparation and bioprocess systems; powder and solid systems; clean utility equipment and systems; clean room, automation control, and monitor systems; and freeze-dryer, sterile filling, and visual inspection equipment. It also provides pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; laboratory one-stop solutions; and single-use bioprocess equipment and consumables. In addition, the company offers design, quality risk control, consulting, research and development support, process engineering, digitalization construction, after-sale, on-site, upgrading, relocation, and asset management services. Further, it is involved in the agency and distribution of pharmaceutical equipment, as well as provides assembly and pre-assembly services. The company was founded in 1991 and is headquartered in Shanghai, China.